Novonesis A/S

CPSE:NSIS B Voorraadrapport

Marktkapitalisatie: DKK 200.8b

Novonesis Beheer

Beheer criteriumcontroles 3/4

We currently do not have sufficient information about the CEO.

Belangrijke informatie

Ester Baiget

Algemeen directeur

€3.9m

Totale compensatie

Percentage CEO-salaris33.3%
Dienstverband CEO4.8yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn3.6yrs
Gemiddelde ambtstermijn bestuur4.8yrs

Recente managementupdates

Recent updates

These 4 Measures Indicate That Novozymes (CPH:NZYM B) Is Using Debt Reasonably Well

Sep 27
These 4 Measures Indicate That Novozymes (CPH:NZYM B) Is Using Debt Reasonably Well

An Intrinsic Calculation For Novozymes A/S (CPH:NZYM B) Suggests It's 22% Undervalued

Sep 05
An Intrinsic Calculation For Novozymes A/S (CPH:NZYM B) Suggests It's 22% Undervalued

Novozymes (CPH:NZYM B) Might Be Having Difficulty Using Its Capital Effectively

Jul 09
Novozymes (CPH:NZYM B) Might Be Having Difficulty Using Its Capital Effectively

Does Novozymes (CPH:NZYM B) Have A Healthy Balance Sheet?

Jun 24
Does Novozymes (CPH:NZYM B) Have A Healthy Balance Sheet?

Calculating The Fair Value Of Novozymes A/S (CPH:NZYM B)

May 02
Calculating The Fair Value Of Novozymes A/S (CPH:NZYM B)

Novozymes (CPH:NZYM B) Might Be Having Difficulty Using Its Capital Effectively

Apr 07
Novozymes (CPH:NZYM B) Might Be Having Difficulty Using Its Capital Effectively

Does Novozymes (CPH:NZYM B) Have A Healthy Balance Sheet?

Mar 26
Does Novozymes (CPH:NZYM B) Have A Healthy Balance Sheet?

Is Now The Time To Put Novozymes (CPH:NZYM B) On Your Watchlist?

Mar 12
Is Now The Time To Put Novozymes (CPH:NZYM B) On Your Watchlist?

Novozymes' (CPH:NZYM B) Profits Appear To Have Quality Issues

Feb 04
Novozymes' (CPH:NZYM B) Profits Appear To Have Quality Issues

Calculating The Fair Value Of Novozymes A/S (CPH:NZYM B)

Jan 29
Calculating The Fair Value Of Novozymes A/S (CPH:NZYM B)

Is Novozymes (CPH:NZYM B) Using Too Much Debt?

Dec 23
Is Novozymes (CPH:NZYM B) Using Too Much Debt?

Returns On Capital At Novozymes (CPH:NZYM B) Paint A Concerning Picture

Dec 05
Returns On Capital At Novozymes (CPH:NZYM B) Paint A Concerning Picture

A Look At The Intrinsic Value Of Novozymes A/S (CPH:NZYM B)

Oct 14
A Look At The Intrinsic Value Of Novozymes A/S (CPH:NZYM B)

These 4 Measures Indicate That Novozymes (CPH:NZYM B) Is Using Debt Reasonably Well

Sep 13
These 4 Measures Indicate That Novozymes (CPH:NZYM B) Is Using Debt Reasonably Well

The Returns On Capital At Novozymes (CPH:NZYM B) Don't Inspire Confidence

Aug 29
The Returns On Capital At Novozymes (CPH:NZYM B) Don't Inspire Confidence

Estimating The Fair Value Of Novozymes A/S (CPH:NZYM B)

Jul 13
Estimating The Fair Value Of Novozymes A/S (CPH:NZYM B)

Here's Why Novozymes (CPH:NZYM B) Can Manage Its Debt Responsibly

Jun 13
Here's Why Novozymes (CPH:NZYM B) Can Manage Its Debt Responsibly

Here's What's Concerning About Novozymes' (CPH:NZYM B) Returns On Capital

May 29
Here's What's Concerning About Novozymes' (CPH:NZYM B) Returns On Capital

Estimating The Intrinsic Value Of Novozymes A/S (CPH:NZYM B)

Apr 12
Estimating The Intrinsic Value Of Novozymes A/S (CPH:NZYM B)

Analyse CEO-vergoeding

Hoe is Ester Baiget's beloning veranderd ten opzichte van Novonesis's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

€283m

Mar 31 2024n/an/a

€332m

Dec 31 2023€4m€1m

€406m

Sep 30 2023n/an/a

€430m

Jun 30 2023n/an/a

€460m

Mar 31 2023n/an/a

€487m

Dec 31 2022€3m€1m

€494m

Sep 30 2022n/an/a

€460m

Jun 30 2022n/an/a

€418m

Mar 31 2022n/an/a

€416m

Dec 31 2021€3m€1m

€423m

Sep 30 2021n/an/a

€427m

Jun 30 2021n/an/a

€409m

Mar 31 2021n/an/a

€389m

Dec 31 2020€3m€927k

€380m

Compensatie versus markt: Ester's total compensation ($USD4.23M) is about average for companies of similar size in the Danish market ($USD3.61M).

Compensatie versus inkomsten: Ester's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.


CEO

Ester Baiget (53 yo)

4.8yrs

Tenure

€3,903,958

Compensatie

Ms. Ester Baiget serves as Chief Executive Officer and President of Novozymes A/S since joining on February 1, 2020. She serves as Member of Supervisory Board at Akzo Nobel N.V. since 2022. She served as t...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Ester Baiget
President & CEO4.8yrs€3.90mgeen gegevens
Rainer Lehmann
Executive VP & CFOless than a year€858.60kgeen gegevens
Anders Lund
Chief Operating Officerless than a year€1.03mgeen gegevens
Claus Fuglsang
Chief Scientific Officer4.2yrsgeen gegevensgeen gegevens
Tobias Bjorklund
Head of Investor Relationsno datageen gegevensgeen gegevens
Tue Micheelsen
Vice President of Global Sales & Marketingno datageen gegevensgeen gegevens
Morten Rasmussen
Executive Vice President of People & Stakeholder Relations3.6yrsgeen gegevensgeen gegevens
Tina Fano
Executive Vice President of Planetary Health Biosolutions8.8yrs€1.02mgeen gegevens
Amy Byrick
Executive Vice President of Human Health Biosolutions3.6yrsgeen gegevensgeen gegevens
Henrik Nielsen
Executive Vice President of Strategy & Integrationless than a yeargeen gegevensgeen gegevens
Jacob Paulsen
Executive Vice President of Food & Beverage Biosolutionsless than a yeargeen gegevensgeen gegevens
Peter Rosholm
Chief Executive Officer of Albumedix8.8yrsgeen gegevensgeen gegevens

3.6yrs

Gemiddelde duur

50yo

Gemiddelde leeftijd

Ervaren management: NSIS B's management team is considered experienced (3.6 years average tenure).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Jesper Brandgaard
Vice Chair of the Boardless than a yeargeen gegevensgeen gegevens
Cornelis de Jong
Independent Chairman4.8yrs€239.07k0.0011%
DKK 2.2m
Kim Stratton
Independent Director7.8yrs€173.33kgeen gegevens
Kasim Kutay
Director7.8yrs€107.73k0.00023%
DKK 461.7k
Heine Dalsgaard
Director4.8yrs€143.55k0.00065%
DKK 1.3m
Lise Kaae
Directorless than a yeargeen gegevensgeen gegevens
Lena Holskov
Employee Representative Director11.8yrs€66.91kgeen gegevens
Anders Knudsen
Employee Representative Director11.8yrs€71.77kgeen gegevens
Sharon James
Independent Director4.8yrs€143.55kgeen gegevens
Preben Nielsen
Employee Representative Director3.7yrs€107.73k0.000090%
DKK 180.7k
Jens Obro
Employee Representative Director3.7yrs€71.77k0.00012%
DKK 240.9k
Morten Otto Sommer
Independent Director2.7yrs€137.51k0.00022%
DKK 441.7k

4.8yrs

Gemiddelde duur

58.5yo

Gemiddelde leeftijd

Ervaren bestuur: NSIS B's board of directors are considered experienced (4.8 years average tenure).